Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-8

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19)(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Name:	us-gaap_OtherLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Accrued and Other Current Liabilities - Additional Information (Details) - USD ($)	1 Months Ended
	Dec. 31, 2022	Jun. 30, 2026	Dec. 31, 2025
Other Liabilities Current [Line Items]
Other current liabilities		$ 2,454,258	$ 2,847,543
Research and Development Agreement
Other Liabilities Current [Line Items]
Other current liabilities		$ 2,400,000	$ 2,500,000
Research and Development Agreement \| Location, Statement of Income, Balance [Axis]: us-gaap:OtherNonoperatingIncomeExpense
Other Liabilities Current [Line Items]
Repayable advance received	$ 2,400,000